Cognetivity Neurosciences Valuation
| CGNSF Stock | USD 0.01 0 10.00% |
Cognetivity Neurosciences seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of Cognetivity Neurosciences from analyzing the firm fundamentals such as Current Valuation of 15.68 M, return on equity of -6.43, and Shares Owned By Insiders of 14.69 % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Cognetivity Neurosciences' price fluctuation is out of control at this time. Calculation of the real value of Cognetivity Neurosciences is based on 3 months time horizon. Increasing Cognetivity Neurosciences' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Cognetivity pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Cognetivity Neurosciences. Since Cognetivity Neurosciences is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Cognetivity Pink Sheet. However, Cognetivity Neurosciences' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.009 | Real 0.00651 | Hype 0.01 | Naive 0.0118 |
The real value of Cognetivity Pink Sheet, also known as its intrinsic value, is the underlying worth of Cognetivity Neurosciences Company, which is reflected in its stock price. It is based on Cognetivity Neurosciences' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Cognetivity Neurosciences' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Cognetivity Neurosciences helps investors to forecast how Cognetivity pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Cognetivity Neurosciences more accurately as focusing exclusively on Cognetivity Neurosciences' fundamentals will not take into account other important factors: Cognetivity Neurosciences Total Value Analysis
Cognetivity Neurosciences is currently projected to have takeover price of 15.68 M with market capitalization of 20.53 M, debt of 1.37 M, and cash on hands of 61.23 K. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Cognetivity Neurosciences fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
15.68 M | 20.53 M | 1.37 M | 61.23 K |
Cognetivity Neurosciences Asset Utilization
One of the ways to look at asset utilization of Cognetivity is to check how much profit was generated for every dollar of assets it reports. Cognetivity Neurosciences shows a negative utilization of assets of -2.04 percent, losing $0.0204 for each dollar of assets held by the firm. Inadequate asset utilization signifies that the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of Cognetivity Neurosciences shows how discouraging it operates for each dollar spent on its assets.Cognetivity Neurosciences Ownership Allocation
Cognetivity Neurosciences holds a total of 85.05 Million outstanding shares. Cognetivity Neurosciences shows 14.69 percent of its outstanding shares held by insiders and 0.0 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Cognetivity Neurosciences Profitability Analysis
Net Loss for the year was (13.13 M) with loss before overhead, payroll, taxes, and interest of (4.02 M).Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Cognetivity Neurosciences' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Cognetivity Neurosciences and how it compares across the competition.
About Cognetivity Neurosciences Valuation
The pink sheet valuation mechanism determines Cognetivity Neurosciences' current worth on a weekly basis. Our valuation model uses a comparative analysis of Cognetivity Neurosciences. We calculate exposure to Cognetivity Neurosciences's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Cognetivity Neurosciences's related companies.Cognetivity Neurosciences Ltd. operates as a healthcare company. Cognetivity Neurosciences Ltd. was incorporated in 2015 and is headquartered in Vancouver, Canada. Cognetivity Neurosciences operates under Health Information Services classification in the United States and is traded on OTC Exchange.
8 Steps to conduct Cognetivity Neurosciences' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Cognetivity Neurosciences' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Cognetivity Neurosciences' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Cognetivity Neurosciences' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Cognetivity Neurosciences' revenue streams: Identify Cognetivity Neurosciences' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Cognetivity Neurosciences' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Cognetivity Neurosciences' growth potential: Evaluate Cognetivity Neurosciences' management, business model, and growth potential.
- Determine Cognetivity Neurosciences' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Cognetivity Neurosciences' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Cognetivity Neurosciences Growth Indicators
Investing in growth stocks can be very risky. If the company such as Cognetivity Neurosciences does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 79.4 M | |
| Forward Price Earnings | 25.7732 | |
| Retained Earnings | -24 M |
Complementary Tools for Cognetivity Pink Sheet analysis
When running Cognetivity Neurosciences' price analysis, check to measure Cognetivity Neurosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cognetivity Neurosciences is operating at the current time. Most of Cognetivity Neurosciences' value examination focuses on studying past and present price action to predict the probability of Cognetivity Neurosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cognetivity Neurosciences' price. Additionally, you may evaluate how the addition of Cognetivity Neurosciences to your portfolios can decrease your overall portfolio volatility.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |